Results 151 to 160 of about 680,918 (208)

Radiotherapy after Neoadjuvant Immunochemotherapy in Unresectable Stage III Non-Small Cell Lung Carcinoma: A Novel Therapeutic Approach? [PDF]

Precis Radiat Oncol
Wu P, Li C, Wei Z, Meng X.
europepmc   +1 more source

Small cell lung carcinoma with YAP1 expression and SMARCA4-deficient undifferentiated tumors. [PDF]

Transl Cancer Res
Hayashi T.
europepmc   +1 more source

Role of Notch1 Signaling Pathway in Small Cell Lung Carcinoma. [PDF]

Iran J Pathol
Charbat MA, Abdulhalim YH, Alrabeei MA, Abdo Hassan W.   +3 more
europepmc   +1 more source

PIK3CA Mutations and Co-Mutations in Operated Non-Small Cell Lung Carcinoma. [PDF]

J Clin Med
Cokpinar S, Erdogdu IH, Orenay-Boyacioglu S, Boyacioglu O, Kahraman-Cetin N, Meteoglu I.   +5 more
europepmc   +1 more source

Real-world description of patients with resected epidermal growth factor receptor mutation positive non-small cell lung carcinoma treated with adjuvant osimertinib in an early access program in Italy: the ELBA observational study. [PDF]

Front Oncol
Pasello G, Proto C, Genova C, Pavan A, Roca E, Minuti G, D'Aniello C, Giusti R, Mariotti S, Romano FJ, Polo V, Belluomini L, Baldini E, Mazzoni F, Bettini AC, Gristina V, Russo A, Grossi F, Ogliari FR, Gelsomino F, Chiari R, Bria E, Fioroni I, Cortinovis D, Pizzutilo EG, Zanetti A, Pasqualetti G, Roncari B, Simoni L, Catino A, ELBA Study Group .   +30 more
europepmc   +1 more source

Retrospective prognostic evaluation and single-cell transcriptomic analyses of non-small cell lung carcinoma with malignant pleural effusion. [PDF]

Transl Cancer Res
Wu P, Gao R, Zhao K, Meng X.
europepmc   +1 more source

Pembrolizumab in PD-L1-positive advanced non-small cell lung carcinoma: A meta-analysis of survival benefits and immune-related toxicity events patterns. [PDF]

ADMET DMPK
Chakramurty A, Dinni AR, Silvia I, Cantika AL, Wungu CDK.   +4 more
europepmc   +1 more source

Prognostic Indicators for Precision Treatment of Non-Small Cell Lung Carcinoma. [PDF]

Cells
Ghosh DD, McDonald H, Dutta R, Krishnan K, Thilakan J, Paul MK, Arya N, Rao M, Rangnekar VM.   +8 more
europepmc   +1 more source

A Recurrent Small Cell Lung Carcinoma Harboring an EML4-ALK Fusion Mutation with Sustained Response to Ensartinib: A Case Report. [PDF]

Curr Oncol
Jiang H, Zhu T, Chang Z, Liu Z, Ou W, Wang S.   +5 more
europepmc   +1 more source